Was 2022 Novo Nordisk A/S's best revenue year?

No. Novo Nordisk A/S's highest recorded revenue year was 2024 at $42.7B. In 2022, Novo Nordisk A/S reported $24.8B.

What was Novo Nordisk A/S's highest ever annual revenue?

Novo Nordisk A/S's highest ever annual revenue was $42.7B recorded in fiscal year 2024.

Novo Nordisk A/S

PharmaceuticalsFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Explore Novo Nordisk A/S

Core profile pages, annual revenue records, and related research hubs for this company.

Novo Nordisk A/S

PharmaceuticalsFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Annual Revenue

Novo Nordisk A/S Revenue in 2022

Q: What was Novo Nordisk A/S's revenue in 2022?

Novo Nordisk A/S reported $24.8B in revenue for fiscal year 2022. Novo Nordisk posted $24.8 billion in FY2022, the baseline year before incretin demand propelled its Danish pharmaceutical business to historic growth rates.

FY2022 Revenue

$24.8B

Source: Annual report / company filing

Novo Nordisk A/S reported $24.8B in revenue for fiscal year 2022. In 2023, revenue increased to $33.4B.

Novo Nordisk posted $24.8 billion in FY2022, the baseline year before incretin demand propelled its Danish pharmaceutical business to historic growth rates.

Revenue by Year

FY2024 FY2023 FY2022

Novo Nordisk A/S Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2024	$42.7B	$14.3B	+27.8%
FY2023	$33.4B	—	+34.7%
FY2022	$24.8B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Next year →

FY2023: $33.4B

Explore Novo Nordisk A/S

Core profile pages, annual revenue records, and related research hubs for this company.